Alimta (Pemetrexed For Injection)

We are pleased to Distribute, Supply and Trade of ALIMTA (pemetrexed for injection) in Ahmedabad, Gujarat, India.

ALIMTAAR (pemetrexed for injection) is approved by the FDA in combination with (another chemotherapy drug) for the initial treatment of advanced nonsquamous non-small cell lung cancer (NSCLC), a specific type of NSCLC. ALIMTA is not indicated for patients who have different type of NSCLC called squamous cell.
To Maintain the Effect of Initial Chemotherapy Before Worsening of Advanced or Metastatic Nonsquamous Non-Small Cell Lung Cancer

ALIMTA is approved by the FDA for the treatment of patients with advanced nonsquamous non-small cell lung cancer (NSCLC), a specific type of NSCLC, to maintain the effect of initial treatment with chemotherapy and whose disease has not worsened. ALIMTA is not indicated for patients who have a different type of NSCLC called squamous cell.

ALIMTA is approved by the FDA as a single agent (used alone) for the treatment of patients with advanced nonsquamous non-small cell lung cancer (NSCLC), a specific type of NSCLC, after prior chemotherapy. ALIMTA is not indicated for patients who have a different type of NSCLC called squamous cell.
Treatment for Malignant Pleural Mesothelioma

ALIMTA is a treatment for malignant pleural mesothelioma (MPM), which is a cancer that affects the inside lining of the chest cavity. ALIMTA is given with , another anticancer medicine (chemotherapy), when surgery is not an option.